Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 and up Women only

Improving management of preterm premature rupture of membranes with antibiotics

Official title: Improvement of PPROM Management With Prophylactic Antimicrobial Therapy

Run by Ohio State University · NCT06396078 · Data updated 2026-11-12

This study is testing if a new combination of antibiotics can help pregnant people with preterm premature rupture of membranes stay pregnant longer and have healthier babies compared to the usual treatment.

More Preterm Birth trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment56 (estimated)
SponsorOhio State University
Academic / other
Locations2 sites (Columbus, Ohio and 1 other locations)
StatusRecruiting
StartedJuly 18, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJanuary 27, 2026
Trial IDNCT06396078 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant individuals aged 18 and older, between 23 and 32 weeks of gestation, who are admitted for expectant management of PPROM.

Probably not a fit

Patients who have received more than one dose of prophylactic antibiotics or have a suspected or confirmed infection requiring treatment may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of a new antibiotic regimen consisting of ceftriaxone, clarithromycin, and metronidazole compared to the standard treatment of ampicillin/amoxicillin and azithromycin or erythromycin for pregnant individuals with preterm premature rupture of membranes (PPROM). The study aims to prolong pregnancy and reduce adverse perinatal outcomes by administering these antibiotics during hospitalization for expectant management. Participants will be randomly assigned to receive either treatment for a duration of seven days, and outcomes will be monitored to assess the efficacy of the new regimen. The trial is designed as an unblinded pragmatic randomized controlled trial to reflect real-world clinical practice.

Why it matters

Potential benefit: If successful, this study could lead to improved pregnancy outcomes and reduced complications for patients with PPROM.

How similar studies have gone: Previous observational studies have shown success with similar antibiotic regimens, indicating potential for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria

* Admitted to the inpatient unit for expectant management of PPROM until delivery
* Age ≥ 18 years with the ability to provide informed consent
* Gestational age between 23 0/7 and 32 6/7 weeks

Exclusion criteria

* Having received more than one dose of any prophylactic antibiotic
* Suspected or confirmed infection requiring treatment with antibiotics
* Allergy or contraindication to an antibiotic in either arm
* Maternal immunosuppression

Where it's running

  • The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine
    Columbus, Ohio, United States
    Recruiting
  • University of Texas Medical Branch
    Galveston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.